NEW YORK (GenomeWeb News) – Following last week’s merger of Applied Biosystems and Invitrogen to create Life Technologies, the combined firm has appointed three former directors of ABI to its board: Arnold Levine, George Adam, and William Longfield.
 
Levine will serve as a member of the board’s Science and Technology Committee, Adam will serve as a member of the Audit Committee, and Longfield will serve as a member of the Compensation and Organizational Committee.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.